Rubius Therapeutics Announces Publication of RTX-321 Preclinical Data in Nature Communications
Preclinical Data Demonstrate RTX-321 Potently Activates and Expands HPV 16-Reactive Anti-Tumor T Cells and Provides Broad Immune StimulationCAMBRIDGE, Mass., May...